Dr. Liebisch - Prognostic Impact of Chromosomal Abnormalities in Elderly Patients with Multiple Myeloma Treated with High-Dose Melphalan (MEL140) and Autologous Stem Cell Transplantation
Peter Liebisch, MD University Hospital of Ulm Ulm, Germany
12.23.07
To view the video full screen, click on the small
button next to the volume control in the
lower right hand corner.
button next to the volume control in the
lower right hand corner.
print
related articles